Clinical Trial Update: CHED - Congenital Hereditary Endothelial Dystrophy: New Paradigm Shift in Therapy Using Topical Eye Drops [Phase 2]

View source ↗

Summary

Phase 2 trial update for a topical eye drop therapy targeting Congenital Hereditary Endothelial Dystrophy of the Cornea.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Hereditary Endothelial Dystrophy of the Cornea

Snippet

Sponsor: L.V. Prasad Eye Institute | Conditions: Congenital Hereditary Endothelial Dystrophy of Cornea | Phase 2 | Status: UNKNOWN